Around 670 people in England with epidermolysis bullosa will benefit from the treatment More: NICE recommends Amryt’s Filsuvez for rare skin disorder Source: News
read moreKRAS crisis? FDA will gather advisers to weigh full approval for Amgen’s Lumakras aliu Mon, 08/21/2023 – 14:32 More: KRAS crisis? FDA will gather advisers to weigh full approval for Amgen's Lumakras Source: fierce
read moreAlembic and Aurobindo issue US drug recalls, citing quality and production issues jkeenan Mon, 08/21/2023 – 14:05 More: Alembic and Aurobindo issue US drug recalls, citing quality and production issues Source: fierce
read moreJohnson & Johnson to keep a 9.5% stake in consumer health spinoff Kenvue stake after exchange offer zbecker Mon, 08/21/2023 – 10:47 More: Johnson & Johnson to keep a 9.5% stake in consumer health spinoff Kenvue stake after exchange offer
read moreAfter Regeneron scores FDA nod for high-dose Eylea, it’s game on in showdown with Roche’s Vabysmo kdunleavy Mon, 08/21/2023 – 10:31 More: After Regeneron scores FDA nod for high-dose Eylea, it’s game on in showdown with Roche’s Vabysmo Source: fierce
read moreAARP joins Justice Department’s bid to knock down industry lawsuit targeting IRA pricing negotiations fkansteiner Mon, 08/21/2023 – 10:30 More: AARP joins Justice Department's bid to knock down industry lawsuit targeting IRA pricing negotiations Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals